REG - Haleon PLC - Publication of Annual Report 2025 & Notice of AGM

HALEONAnnouncement

13/03/2026 14:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260313:nRSM6377Wa&default-theme=true

RNS Number : 6377W  Haleon PLC  13 March 2026

 

Haleon plc: Publication of Annual Report and Form 20-F 2025 and Notice of 2026
AGM

 

13 March 2026: Haleon plc (the "Company") announces that the following
documents have been published today and are available on its website,
www.haleon.com (http://www.haleon.com) :

 

-    Annual Report and Accounts & Form 20-F 2025 (the 'Annual Report');
and

-    Notice of 2026 Annual General Meeting ('AGM').

 

In addition, in accordance with Section 203.01 of the New York Stock Exchange
Listed Company Manual, the Annual Report & Form 20-F 2025 will also today
be filed with the US Securities and Exchange Commission and will shortly be
available at www.sec.gov (http://www.sec.gov) .

 

Haleon's AGM will again be a virtual meeting taking place at 3.00pm (BST) on
Wednesday, 29 April 2026. The Notice of 2026 AGM is available on the Company's
website at
https://www.haleon.com/investors/shareholder-information/annual-general-meetings
(https://www.haleon.com/investors/shareholder-information/annual-general-meetings)
, and includes full details of the business to be conducted and joining
instructions.

 

Amanda Mellor

Company Secretary

 

About Haleon

Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused on better
everyday health. Our people, our brands, our research, our investment and our
innovation are aimed at improving the everyday health of consumers. Our
product portfolio spans six major categories - Oral Health, Vitamins, Minerals
and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and
Therapeutic Skin Health and Other. Our superior brands - such as Advil,
Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and
Voltaren - are trusted by more than one billion consumers and are recommended
by health professionals around the world.

 

For more information, please visit www.haleon.com (http://www.haleon.com/)
.

 

Notes

In compliance with the Disclosure Guidance and Transparency Rules, the Annual
Report, as submitted to the National Storage Mechanism, contains regulated
information in unedited full text and is available on the Company's website as
noted above.

 

In compliance with UK Listing Rules 6.4.1(R) and 6.4.3(R) copies of the Annual
Report, Notice of AGM, Form of Proxy for the 2026 AGM and Voting Instruction
Card have been submitted to the National Storage Mechanism and will shortly be
available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

 

Shareholders may request a free hard copy of the Annual Report, including the
complete audited financial statements of the Company. Requests should be
directed to corporate.secretariat@haleon.com
(mailto:corporate.secretariat@haleon.com) .

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ACSJJMJTMTIBBRF



            Copyright 2019 Regulatory News Service, all rights reserved